Arrowhead Research | Eigenkapital Und Reserven

Equity Capital And Reserves Veränderung Datum
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Ligand Pharmaceuticals USD 700.91M 33.02M 2023-12
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
TG Therapeutics USD 160.5M 4.27M 2023-12
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09
Xencor USD 668.8M 214K 2023-12



Arrowhead Research Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.